1. Home
  2. NBY vs SAR Comparison

NBY vs SAR Comparison

Compare NBY & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$15.78

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

HOLD

Current Price

$23.58

Market Cap

369.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
SAR
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
369.9M
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
NBY
SAR
Price
$15.78
$23.58
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$23.75
AVG Volume (30 Days)
3.2M
115.6K
Earning Date
11-07-2025
01-07-2026
Dividend Yield
6.30%
13.65%
EPS Growth
N/A
0.54
EPS
0.47
2.50
Revenue
$10,302,000.00
$125,884,990.00
Revenue This Year
$23.91
N/A
Revenue Next Year
$32.05
$1.38
P/E Ratio
$493.09
$9.52
Revenue Growth
390.34
N/A
52 Week Low
$0.46
$21.10
52 Week High
$19.95
$26.17

Technical Indicators

Market Signals
Indicator
NBY
SAR
Relative Strength Index (RSI) 69.49 57.94
Support Level $10.42 $22.88
Resistance Level $19.95 $23.91
Average True Range (ATR) 3.14 0.37
MACD 0.59 0.04
Stochastic Oscillator 73.24 80.00

Price Performance

Historical Comparison
NBY
SAR

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: